Cutaneous metastasis of PD-L1 positive cervical carcinoma

• Cutaneous metastases in cervical cancer are rare and associated with a poor prognosis. • Treatment is typically palliative, utilizing chemotherapy and radiation. • We report a case of PD-L1 positive cervical cancer with cutaneous metastases that developed after initial recurrence. • For patients o...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Chrissy, Zhou, Nancy, Levitan, Daniel, Coca Guzman, Juan, Fehniger, Julia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142653/
https://www.ncbi.nlm.nih.gov/pubmed/35638094
http://dx.doi.org/10.1016/j.gore.2022.101003
_version_ 1784715620642717696
author Liu, Chrissy
Zhou, Nancy
Levitan, Daniel
Coca Guzman, Juan
Fehniger, Julia
author_facet Liu, Chrissy
Zhou, Nancy
Levitan, Daniel
Coca Guzman, Juan
Fehniger, Julia
author_sort Liu, Chrissy
collection PubMed
description • Cutaneous metastases in cervical cancer are rare and associated with a poor prognosis. • Treatment is typically palliative, utilizing chemotherapy and radiation. • We report a case of PD-L1 positive cervical cancer with cutaneous metastases that developed after initial recurrence. • For patients on checkpoint inhibitor therapy who develop skin toxicity, it is important to rule out cutaneous metastases.
format Online
Article
Text
id pubmed-9142653
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91426532022-05-29 Cutaneous metastasis of PD-L1 positive cervical carcinoma Liu, Chrissy Zhou, Nancy Levitan, Daniel Coca Guzman, Juan Fehniger, Julia Gynecol Oncol Rep Case Report • Cutaneous metastases in cervical cancer are rare and associated with a poor prognosis. • Treatment is typically palliative, utilizing chemotherapy and radiation. • We report a case of PD-L1 positive cervical cancer with cutaneous metastases that developed after initial recurrence. • For patients on checkpoint inhibitor therapy who develop skin toxicity, it is important to rule out cutaneous metastases. Elsevier 2022-05-18 /pmc/articles/PMC9142653/ /pubmed/35638094 http://dx.doi.org/10.1016/j.gore.2022.101003 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Liu, Chrissy
Zhou, Nancy
Levitan, Daniel
Coca Guzman, Juan
Fehniger, Julia
Cutaneous metastasis of PD-L1 positive cervical carcinoma
title Cutaneous metastasis of PD-L1 positive cervical carcinoma
title_full Cutaneous metastasis of PD-L1 positive cervical carcinoma
title_fullStr Cutaneous metastasis of PD-L1 positive cervical carcinoma
title_full_unstemmed Cutaneous metastasis of PD-L1 positive cervical carcinoma
title_short Cutaneous metastasis of PD-L1 positive cervical carcinoma
title_sort cutaneous metastasis of pd-l1 positive cervical carcinoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142653/
https://www.ncbi.nlm.nih.gov/pubmed/35638094
http://dx.doi.org/10.1016/j.gore.2022.101003
work_keys_str_mv AT liuchrissy cutaneousmetastasisofpdl1positivecervicalcarcinoma
AT zhounancy cutaneousmetastasisofpdl1positivecervicalcarcinoma
AT levitandaniel cutaneousmetastasisofpdl1positivecervicalcarcinoma
AT cocaguzmanjuan cutaneousmetastasisofpdl1positivecervicalcarcinoma
AT fehnigerjulia cutaneousmetastasisofpdl1positivecervicalcarcinoma

Ejemplares similares